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Sequence-specific validation of LAMP amplicons in real-time 
optomagnetic detection of Dengue serotype 2 synthetic DNA  
Gabriel Antonio S. Mineroa, Catarina Nogueirab, Giovanni Rizzia, Bo Tianc, Jeppe Focka, Marco 
Donolatob, Mattias Strömbergc, and Mikkel F. Hansena 
We report on an optomagnetic technique optimised for real-time molecular detection of Dengue fever virus under ideal as 
well as non-ideal laboratory conditions using two different detection approaches. The first approach is based on the 
detection of the hydrodynamic volume of streptavidin coated magnetic nanoparticles attached to biotinylated LAMP 
amplicons. We demonstrate detection of sub-femtomolar Dengue DNA target concentrations in the ideal contamination-
free lab environment within 20 min. The second detection approach is based on sequence-specific binding of 
functionalised magnetic nanoparticles to loops of LAMP amplicons. Melting studies reveal that true positive and spurious 
amplicons have different melting points and this allows us to discriminate between them. This is found to be in a good 
agreement with subsequent studies on real-time sequence-specific discrimination of LAMP amplicons. The specific binding 
causes clustering of magnetic nanoparticles via binding to multiple sites (loops) emerging in the elongation phase of LAMP. 
Formation of nanoclusters is monitored via the depletion of the optomagnetic signal due to free nanoparticles. After 
sequence-specific validation, we claim detection of down to 100 fM of Dengue target after 20 min of LAMP with a 
contamination background. 
Introduction 
Loop-mediated isothermal amplification (LAMP) is a powerful 
single-tube isothermal nucleic acid amplification technique yielding 
billions of copies from less than 10 copies of input template (DNA or 
RNA) within 1 hour.1 In this technique, a template with a length of 
about 200 nucleotides is converted into a dumbbell structure with 
single-stranded loops to which primers hybridise and are extended 
under isothermal conditions.1–3 Due to the isothermal operation 
and high sensitivity, LAMP is promoted for molecular diagnostics in 
peripheral laboratories of developing countries.4 
Routine end-point detection of LAMP amplicons can be performed 
by gel electrophoresis,2 by visual inspection of turbidity,3 or via the 
colour of a magnesium-sensitive indicator.4–6 The LAMP technique 
has been implemented on a disk7 and in a lateral flow device.8 
Reports have emerged on multiplex readout of LAMP products by 
fluorescent probes targeting loops,9 by quenching of fluorescence 
from unincorporated inner primers,10 by multiple endonuclease 
restriction to generate fluorescence signal from the incorporated 
inner primers,11 and by appearance of fluorescence when quencher 
strands are displaced via toehold-mediated binding of DNA 
probes.12 DuVall et al. presented a bead-based LAMP assay on a 
chip that detected the inhibition of large amounts of amplicons on 
the aggregation of magnetic beads under chaotropic conditions.13 
Recently, we reported on a nanoparticle-based approach using 
susceptometric14 and optomagnetic15 readouts where LAMP 
amplicons bound to magnetic nanoparticles (MNPs) via biotinylated 
primers were detected as an increase in the hydrodynamic size of 
the MNPs. In Ref. 15, the optomagnetic detection of Newcastle 
virus disease RNA was performed after mixing MNPs with a fraction 
of the sample after completion of the LAMP reaction. In Ref. 14, the 
susceptometric detection of Zika virus oligonucleotide was 
performed with the MNPs present in the reaction mixture during 
amplification, but the measurement was performed at end-point 
due to the long measurement time (15 min) and the lack of 
integration of temperature control with the readout system. 
The use of LAMP to generate large amounts of a desired product is 
a double-edged sword.16,17 Among the challenges of LAMP are: (1) 
complex primer design, (2) assay optimization (choice of enzyme, 
magnesium concentration,14 additives, temperature, etc.), and (3) 
cross-contamination. Failure to amplify under optimum conditions 
may lead to generation of multiple undefined and unwanted 
products and even to the exclusion of the desired product. It is 
recommended to not open reaction vials1 near the lab where LAMP 
samples are prepared and to terminate the reaction at 80°C after a 
certain threshold time.4 Even an optimised assay requires avoiding 
leakage during LAMP,1 because accumulation of amplicon-
containing aerosols in the lab environment causes false-positive 
signals. Maintaining extremely high standards of cleanliness 
(separation of labs, changing lab coats, etc.) is required in order to 
avoid occurrence of spurious (parasitic) amplicons. Research groups 
maintaining all of the mentioned precautions achieved specific 
amplification of pathogens with limits of detection (LODs) down to 
a few copies of, for example, 1 aM of Dengue fever virus5 and Zika 
virus.8  
Recently, modifications of the LAMP technique to relax the above 
strict requirements have been introduced to enable LAMP to be 
performed in a single lab with lower requirements on 
contamination by amplicons from previous LAMP processes. These 
are typically based on the fact that the products formed from such 
amplicons are subject to accumulation of mutations outside the 
regions targeted by the primers. For example, Bst polymerase used 
in LAMP is estimated to introduce about one error every 5500 
bases. Such order of fidelity is also claimed for the error prone Taq 
DNA polymerase used in the gold standard PCR.18 Amplicons can be 
discriminated, for example, via sequence-specific validation of 
single-stranded loops.9 For more efficient validation, toehold strand 
displacement mechanisms can be applied,12,19 which can further 
improve sensitivity via conformational recycling of the targeted 
  
  
sequence.16 Using a two-step readout based on catalysed hairpin 
assembly, the Ellington group demonstrated specific detection of a 
model template with an LOD of 6 copies after 1.5 h.16 Further, with 
the use of a “protected” fluorescent probe complementary to one 
of the loops in a simpler assay format, they demonstrated real-time 
detection of 20 copies (1 aM) of target with a threshold time of 
about 2 h.12  
Analysis made by J. Qian et al.20 revealed that polymerases have a 
higher affinity for purine oligonucleotides and hence that GA-rich 
templates may promote non-specific amplification. Betaine reduces 
the dependence of DNA melting on base composition.21 Therefore, 
it is often used in amplification assays to reduce stability of 
mismatched priming. For exponential amplification reactions 
(EXPAR) suffering from similar cross-contamination constraints, 
blocking of spurious amplicons by the DNA mismatch repair protein 
MutS prevents strand displacement on such templates and hence 
reduces spurious amplification.22 A single-stranded binding protein 
may reduce mismatched hybridisation by a similar mechanism.23 
Recently, K. Hsieh et al. demonstrated a way to suppress “parasitic” 
amplification in LAMP by use of UTP instead of TTP in the LAMP 
cocktail and by introducing a pre-amplification UTP digestion step 
with heat-labile uracil-DNA-glycosylase.24,25 
The detection of the product of an exponential amplification assay 
can be done at the end-point after a fixed amplification time or in 
real-time during the amplification. In the former case, the answer is 
typically “yes” or “no” depending on whether the amplicon signal 
exceeds the detection threshold. In the latter case, a dose-
dependent signal can be determined from the threshold time at 
which the signal becomes detectable. The exponential amplification 
makes these techniques very sensitive to a variation in detection 
time.26 Compared to end-point detection, real-time monitoring of 
the amplicon growth during LAMP provides a more accurate dose-
dependent analysis.  
In this work, we chose Dengue Serotype 2 synthetic DNA (D2) as a 
model target for real-time optomagnetic detection of LAMP 
amplicons. Following work of Lau et al.5, we used a set of primers 
targeting conservative 3’-NCR (non-coding region) of D2 genome. 
Hu et al. demonstrated amplification and differentiation of Dengue 
virus serotype 1-4 targeting corresponding genomic regions coding 
non-structural proteins NS2A (D1), NS4B (D2), NS4A (D3) and 3’-
untraslated region (D4).27 Multiplexed LAMP with sequence-specific 
detection of all four Dengue serotypes in a single tube was shown in 
Dauner et al.28  
The World Health Organization reported the Dengue virus as major 
public-health concern throughout tropical and sub-tropical regions 
of the world.29 Every year, 50 to 100 million people are infected and 
at least 30,000 people die. Clinical requirements concerning 
sensitivity of early Dengue diagnostics were reported as 106 pfu/ml 
in serum30 and 103-106 RNA copies/ml in serum.5 Successful trial on 
Dengue diagnostics in non-ideal conditions was demonstrated by 
Abd El Wahed et al., however, implemented using a different 
amplification technique.31  
Here, we first demonstrate real-time measurements of the size 
increase of MNPs with attached amplicons using an optomagnetic 
technique during LAMP (detection approach I). Under ideal 
laboratory working conditions we obtain a sub-femtomolar LOD 
with a threshold time of 20 min. Next, we investigate an alternative 
detection strategy (detection approach II) based on capture probes 
targeting the loops of the LAMP products. We present real-time 
monitoring of melting of DNA duplexes (bridges) formed between 
capture probes (on MNPs) and looped LAMP amplicons and show 
that such measurements can be used to discriminate between true 
and spurious LAMP amplicons. Finally, we employ this 
discrimination in a real-time detection format that detects the 
depletion of free MNPs as they bind to true positive LAMP 
amplicons and form clusters.  
Using sequence-specific clustering of MNPs on the amplicons, we 
demonstrate a 100 fM LOD of Dengue DNA with an assay time of 
20 min in a single laboratory, which has been used extensively for 
LAMP amplification and with a spurious LAMP amplicon background 
of 100 fM. The presented research contributes to better 
understanding and tailoring of LAMP steps towards diagnostics of 
such severe diseases as Dengue Fever in real lab conditions. 
  
Materials and Methods 
Optomagnetic setup 
The basic working principle of the optomagnetic technique as 
implemented by us has been reported elsewhere.15,32–34 In brief, the 
optomagnetic method relies on the coupled magnetic and optical 
anisotropies of 100 nm MNPs as well as of MNP clusters. The 
technique probes the 2nd harmonic modulation of light transmitted 
through a suspension of MNPs in response to a magnetic field 
𝑩𝑩(𝒕𝒕) = 𝑩𝑩𝟎𝟎𝐬𝐬𝐬𝐬𝐬𝐬 (𝟐𝟐𝟐𝟐𝟐𝟐𝒕𝒕) applied along the light path. PMMA rods 
guided the light from the light source to the chip and from the chip 
to the photodetector. The photodetector voltage vs. time was 
measured using a data acquisition card and the cosine and sine 
components of the signal modulation at 𝟐𝟐𝟐𝟐 were found in LabView 
using a fast Fourier transformation algorithm. The novelty of the 
setup in the present study compared to our previous work15,35 lies 
in the integration of real-time optomagnetic measurements with 
double-sided top and bottom heaters of a plastic chip with light 
access via the chip side (Fig. S1). In the present setup, we used light 
emitting diodes with a wavelength of 470 nm and a magnetic field 
with 𝑩𝑩𝟎𝟎 =0.8 mT. A full sweep of the frequency of the magnetic 
field measuring 41 points between 1 Hz and 2800 Hz was recorded 
in 40 s. For further details on this setup, see Section S1 of the 
electronic supplementary information (ESI†). 
The relevant data for the present study is the real component of the 
2nd harmonic of the transmitted light intensity, 𝑽𝑽𝟐𝟐′ , which gives the 
component of the signal proportional to 𝐬𝐬𝐬𝐬𝐬𝐬 (𝟒𝟒𝟐𝟐𝟐𝟐𝒕𝒕). Individual 
MNPs with a size of 100 nm give rise to a negative signal in 𝑽𝑽𝟐𝟐′  with 
a peak positioned at 𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 ≈ 𝟐𝟐𝐁𝐁/√𝟑𝟑,34 where the Brownian 
relaxation frequency 𝟐𝟐𝐁𝐁 is given by 
𝟐𝟐𝐁𝐁 = 𝒌𝒌𝐁𝐁𝑻𝑻𝟐𝟐𝟐𝟐𝜼𝜼𝑫𝑫𝐡𝐡𝟑𝟑 . (1) 
Here, 𝒌𝒌𝐁𝐁𝑻𝑻 is the thermal energy, 𝜼𝜼 is the viscosity of the liquid, and 
𝑫𝑫𝐡𝐡 is the hydrodynamic MNP diameter. Clusters of MNPs above a 
   
certain size interact differently with the light and display a signal of 
opposite sign (positive peak), which is shifted to lower frequencies 
due to the larger hydrodynamic size of the MNPs. Thus, clustering 
of MNPs results in depletion of the negative signal from single 
MNPs at high frequencies and in the occurrence of a positive signal 
in 𝑽𝑽𝟐𝟐′  at low frequencies.  
 
Chip design and fabrication.  
Custom single-use and disposable polymethylmethacrylate (PMMA) 
chips were fabricated using a CAD design and a CO2-laser (Mini 18, 
30W, Epilog, USA). Rectangular PMMA sheets with thicknesses of 
0.5 mm, 2 mm, and 0.5 mm were joined together using pressure 
sensitive adhesive (PSA, 90106, Adhesive Research, Ireland). In 
addition to alignment holes, the PMMA sheets contained inlet holes 
in the top layer and a chamber (volume of about 75 µl) in the 
middle layer made by the CO2-laser. The PSA was laminated on the 
middle layer, to which the top and bottom layers were bonded. The 
chips were laser cut from the bonded PMMA structures. See 
Section S1, ESI† for more information. 
Magnetic nanoparticles 
All studies were performed with multicore MNPs with a nominal 
mean diameter of 100 nm and a streptavidin surface (BNF-Starch 
streptavidin, prod. code 10-19-102, Micromod Partikeltechnologie 
GmbH, Germany). These MNPs have a remanent magnetic moment 
and we have previously established a clear link between their 
optical and magnetic anisotropies.34 For studies with pre-
functionalised particles, the streptavidin MNPs were functionalised 
with biotinylated DNA probes (Table S1, ESI†) according to a 
previously published protocol to have approximately 100 
probes/MNP33 after which they were resuspended in Tris buffer 
with 0.1% Tween-20. All experiments were performed with a final 
MNP concentration of 0.1 mg/ml (detection approach I) or 0.05 
mg/ml (detection approach II). An MNP mass concentration of 0.1 
mg/ml corresponded to an MNP number concentration of about 
100 pM. 
LAMP reaction setup 
There are four to six primers that each play a different role in LAMP: 
two outer primers, two inner primers (FIP, BIP) and, optionally, 
looped primers (LF, LB). The inner primers have extended 5’-tails: in 
addition to anti-sense sequences (used for priming in the first stage) 
they contain 5’-terminal sense sequences for self-priming in the 
later stages (Fig. 1).2,3 The self-priming and strand displacement 
eliminate the need for thermocycling and thus make LAMP 
isothermal. Furthermore, amplicons, undergo elongation resulting 
in periodic sequence repeats.2 Figure 1 illustrates the LAMP 
technique on MNPs.  
 
Fig. 1: Schematic and simplified illustration of LAMP on streptavidin MNPs. 
Amplicons are attached to streptavidin MNPs (indicated by the yellow 
sphere) via the biotinylated forward inner primer (FIP). (1) Autonomous 
replication of dumbbell structures, (2) extension of internally self-annealed 
3’-end as well as annealing and extension of BIP at the same time, (3) 
extension of internally self-annealed 3’-end and annealing of MNP-free FIP, 
(4) extension of FIP with strand displacement, (5) hybrid structure of dsDNA 
containing newly synthesised strand and ssDNA of doubled length, (6) 
extension of internally self-annealed 3’-end as well as LB (7). 
All reagents for LAMP reaction were purchased from New England 
Biolabs, USA. DNA primer sequences were purchased from LGC 
Biosearch Technologies, Denmark. The LAMP reaction mixture was 
reconstituted from commercial LAMP buffer supported with 4 mM 
magnesium sulfate, 1.4 mM each of dNTP (deoxyribonucleotide 
triphosphates), Bst 3.0 polymerase, primers with the sequences 
adapted from Ref. 5 (Table S1, ESI†), and millipore water (18.2 Ω).  
For detection approach I, the LAMP cocktail was supported with 
1.6 µM biotinylated FIP (5’-biotin), 1.6 µM BIP, 0.4 µM LF and LB, 
and 0.2 µM F3 and B3. For detection approach II, the LAMP cocktail 
was supported with 1.6 µM FIP and BIP, 0.2 µM LB, and 0.2 µM F3 
and B3. Instead of LF, a biotinylated loop validation probe (LV, 3’-
biotin) was used. More details are described in the corresponding 
detection sections. All concentrations refer to the final values in the 
mixture. 
For detection experiments, the D2 target (Integrated DNA 
Technologies, USA, Section S2, ESI†) or water (for the no template 
control, NTC) was added to the mixture to achieve the desired final 
target concentration. Negative control (NC) experiments without 
Bst 3.0 polymerase were also performed to check stability of the 
MNPs in the LAMP cocktail.  
Detection approach I: Capture of amplicons with bio-
tinylated forward inner primers on streptavidin MNPs 
In the first approach, the forward inner primer (FIP) was 
biotinylated such that LAMP amplicons would attach to the 
streptavidin MNPs (Fig. 1). Normally, no clustering of MNPs was 
observed, except for a few cases where primer homodimers were 
formed and detected. 
All pre-amplification pipetting steps were performed in a laminar air 
flow (LAF) bench in a lab separated from the detection lab. All 
components were aliquoted in the LAF bench prior to amplification 
  
  
experiments and stored at −20°C until use where they were 
reconstituted in the LAF bench. 
To perform the experiments, 60 µl of the LAMP mixture was mixed 
with 10 µl of streptavidin MNPs (1 mg/ml) and 30 µl aliquots of the 
D2 target made by serial dilution of the 10 nM stock solution. After 
sample loading, chips were sealed using PSA, transported to the 
detection lab and the liquid was centrifugally driven into the 
detection chamber. The chips were immediately placed inside the 
measurement setup at 40°C. Upon initiation of the optomagnetic 
measurements, the temperature of the heaters was increased to 
67°C where it was kept for the duration of the experiment (50 min) 
during which a spectrum was recorded every 40 s. In each 𝑽𝑽𝟐𝟐′  
spectrum, the position 𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 of the peak was found automatically in 
Matlab using parabolic fitting near the peak to trace 𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 (and 
hence 𝑫𝑫𝐡𝐡) vs. time. The assay was performed at least twice for all 
target concentrations as well as for the no target control samples.   
Detection approach II: Amplicon induced sequence-
specific clustering of functionalised MNPs  
In the second approach, a loop validation (LV) detection probe 
targeting the loop (Table S1, ESI†) was introduced to enable specific 
detection of the LAMP amplicons formed from the D2 target. First, 
melting studies were performed to identify conditions at which 
discrimination between true positive LAMP amplicons and spurious 
amplicons could be obtained. Second, using these conditions, the 
dose-response curve for real-time detection of true positive LAMP 
amplicons under contaminated laboratory conditions was 
investigated. 
DNA melting studies 
LAMP products were prepared by mixing 30 µl D2 target (100 fM, 
300 fM, and 1 pM) with 70 µl LAMP mixture and performing the 
LAMP reaction in a sealed Eppendorf tube in a thermostat at 66°C 
for 1 h. After an enzyme inactivation step (10 min at 80°C), 5 µl of 
LV-functionalised MNP solution (1 mg/ml) was added. Then, the 
mixture was loaded into a chip, which was sealed and placed in the 
measurement setup at 30°C. After 10 min of incubation, a 
temperature sweep was performed by increasing the temperature 
at 0.01°/s while continuously recording optomagnetic spectra (40 s 
per spectrum). The values of 𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 (and hence 𝑫𝑫𝐡𝐡) in the spectra 
were obtained by parabolic fitting and plotted vs. temperature. 
Dose-response curve 
All pre-amplification pipetting steps as well as the amplification and 
detection were performed in a single lab (the detection lab) with no 
special precautions. The laboratory amplicon contamination level 
from spurious LAMP amplicons was estimated to be equivalent to 
100 fM of D2 target DNA (Section S3, ESI†). To perform the 
reaction, 65 µl of the LAMP mixture was mixed with 5 µl of LV-
functionalised MNP solution (1 mg/ml) and 30 µl aliquots of the D2 
target made by serial dilution from the 10 nM stock solution. Chips 
were loaded with samples, sealed and placed in the setup at 40°C. 
Upon initiation of the optomagnetic measurements, the 
temperature of the heaters was increased to 67°C where it was 
kept for the duration of the experiment (25 min). During this time, a 
spectrum was recorded every 40 s.  
In order to monitor sequence-specific clustering of MNPs through 
depletion of the signal from single MNPs, the average optomagnetic 
signal in the frequency range 50-500 Hz, 𝑉𝑉�2′, was obtained and 
plotted vs. time. The assay was performed at least trice for NTC 
samples as well as for each target concentration in the range of 50 – 
1000 fM. 
Results and Discussion 
Detection approach I: Capture of amplicons with bio-
tinylated forward inner primers on streptavidin MNPs 
The ratio of the FIP concentration (1.6 µM) and the MNP 
concentration (≈100 pM) was chosen such that the streptavidin 
MNPs were quickly saturated with the biotinylated FIP. As the 
LAMP amplicon self-primes during the reaction, we expect that at 
most one MNP would be attached to each amplicon during LAMP 
amplification. Therefore, the progress of the LAMP reaction could 
be monitored via the increase of the hydrodynamic size of the 
MNPs (decrease of 𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩) vs. time. Figure 2A shows the 𝑽𝑽𝟐𝟐′  spectra 
measured vs. time for a D2 target concentration of 100 fM. The 
spectra are observed to show a distinct peak, which is shifted from 
𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 ≈ 300 Hz (𝑫𝑫𝐡𝐡 ≈130 nm) to 𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 ≈30 Hz (𝑫𝑫𝐡𝐡 ≈300 nm) over 
the 50 min reaction time. This observation confirms the above 
hypothesis and shows that real-time optomagnetic measurements 
can probe the effective size of the MNPs with attached LAMP 
amplicons vs. time during the reaction. In addition to the shift of 
the peak position in Fig. 2A, we observed a reproducible drop in the 
𝑽𝑽𝟐𝟐
′ /𝑽𝑽𝟎𝟎′  level in the spectra. We attribute this drop to partial co-
sedimentation of functionalised MNPs with magnesium salts 
formed during the LAMP reaction. 
Figure 2B shows the values of 𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 extracted from real-time 
measurements during LAMP reactions with the indicated 
concentrations of D2 target. Measurements on NTC samples were 
performed before and after performing the measurements on the 
dilution series. As expected for exponential amplification, a target 
dilution caused a delay in the response (threshold) time, but it did 
not change the slope of  𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 vs. time. The hydrodynamic size at 
the end-point (20 min) was found to correlate with the target 
concentration, such that a larger size was obtained for a higher 
target concentration. This is consistent with previous results on 
end-point optomagnetic detection of amplicons originating from 
Newcastle disease virus.15 
 
   
 
Fig. 2: Optomagnetic detection of D2 amplicons in the elongation phase of 
LAMP. (A) 𝑉𝑉2′ spectra recorded vs. time (dark green to blue) during the 
LAMP reaction (one spectrum every 40 s) for a target concentration of 
100 fM. (B). Peak position (𝑓𝑓peak) measured vs. amplification time for the 
indicated target concentrations. NTC samples were measured before and 
after the positive samples. The vertical line at 20 min indicates the threshold 
time for detection of 1 fM target. 
While the signal response vs. time depended on the target input 
concentration (Fig. 2B), the change in threshold time obtained for a 
10-fold dilution was at most 3 min. Real-time monitoring of LAMP 
allowed us to detect this difference in the threshold times as well as 
to track the occurrence of false-positive signals. The NTC sample 
run in the clean lab prior to LAMP amplification on positive samples 
showed a completely flat curve, whereas the NTC sample run after 
the experiments on the positive samples showed a signal after 
about 45 min. This tendency was further pronounced after 
repeated experiments (Section S3†). The above results show 
detection of sub-femtomolar concentrations of the target under 
conditions close to “ideal” as a sensitive Yes/No result, which fulfils 
the clinical requirements for early diagnostics of Dengue.30 
It is often difficult to determine the source of contamination. In this 
work, we used custom built PMMA-made chips that were sealed 
manually after loading a sample. Therefore, we could not exclude 
emission of aerosols containing LAMP amplicons from the chips. 
The contamination level in the laboratory environment kept 
increasing to a level corresponding to the signal from a 100 fM 
target. Therefore, only target concentrations higher than 100 fM 
could be discriminated from spurious amplicons in LAMP. This is a 
drawback of using a biotinylated forward inner primer (FIP) since 
the FIP is usually extended even if the amplicon contains mutations 
that tend to accumulate downstream in the sequence. Therefore, 
the impact of sequence specificity of FIP priming on the final 
outcome in LAMP is low, even though LAMP is triggered by six 
primers.  
 
Fig. 3: Alternative optomagnetic detection of true positive (D2) and 
spurious (NTC) amplicons on MNPs using MNPs functionalised with the LF 
primer. Concentration of target in the true positive samples was 300 fM 
while the estimated concentration of spurious amplicons in the NTC samples 
was about 100 fM (Section S3, ESI†). Results of two repeated experiments 
are shown. 
Along this line, we also tested the effect of biotinylating the 3’ end 
of the LF primer instead of the FIP (Fig. 3). The results showed a 
reaction that progressed more slowly (Fig. 3) but that also showed 
higher specificity and ability to distinguish between the NTC 
corresponding to 100 fM target concentration and the positive 
sample. For the FIP-MNPs, the slope of  𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 vs. LAMP time was 
the same for spurious amplicons and the dilution series of D2 
target. For the LF-MNPs, however, inhibition of LAMP was observed 
for the NTC (low slope of 𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 vs. time) compared to the 300 fM 
D2 sample (steep slope vs. time). This can be observed by 
comparing to Fig. 2B, where the only difference between 100 fM 
and 1 pM target concentrations is an offset in the threshold time of 
about 3 min. The higher specificity of the LF-MNPs can be explained 
by the fact that the LF and BF primers are displaced from 
mismatched binding sites during LAMP, without being extended. 
Biotinylation of the LF primer instead of the FIP resulted in better 
discrimination because of its shorter length (LF) and, therefore, 
lower probability to form homodimers.  
Compared to our previous work15 the presented approach I 
eliminates need for post-amplification capture of amplicons on 
MNPs and is, therefore, less error-prone, less labour-intensive, and 
can be used for both real-time measurement and end-point 
detection. 
Detection approach II: Amplicon induced sequence-
specific clustering of functionalised MNPs  
Here, first we demonstrate the evidence for accumulation of 
mutations in the spurious amplicons using DNA melting analysis. 
Then, we demonstrate real-time sequence validation in an 
asymmetric LAMP reaction without the LF primer. This is followed 
by dose-response analysis and discussion. We note that this 
approach has a design and underlying molecular mechanistics, 
which significantly differs from previous studies with MNP-based 
detection of LAMP products.14,15  
DNA melting analysis 
  
  
To search for a readout strategy with better ability to discriminate 
between true positive LAMP amplicons and mutation-containing 
spurious LAMP amplicons, following Li et al.16 we designed a 3’-
biotinylated DNA probe to target one of the emerging loops of the 
LAMP amplicons. We speculate that such a DNA probe would not 
participate in any polymerase-mediated extension due to an MNP 
blocking the 3’-end (Section S2, ESI†). For this, a loop-validating 
(LV) probe (Table S1, ESI†) was used instead of the LF primer in the 
LAMP cocktail and we investigated whether it was possible to find 
conditions where we could discriminate between the binding of LV-
probes to loops of true positive and spurious LAMP amplicons, 
respectively (Section S4, ESI†). 
We therefore conducted LAMP in a true positive sample and a 
contaminated NTC sample and studied the binding properties 
between MNPs with the attached probe (LV) and the amplicons – 
true positive and spurious, respectively - through loop recognition 
(Fig. 4). Upon addition of LV-functionalised MNPs (LV-MNPs) we 
observed within minutes for both samples a shift of 𝟐𝟐𝐩𝐩𝐩𝐩𝐩𝐩𝐩𝐩 from 
about 300 Hz to 10 Hz (Fig. 4A) corresponding to an increase of 𝑫𝑫𝐡𝐡 
from about 130 nm to about 400 nm. This change was due to 
attachment of amplicons to the MNPs.  
 
Fig. 4: Sequence-specific discrimination of true and false amplicons via LV 
capture probes on MNPs detected by DNA melting. (A) End-point sequence-
based detection of 1 pM Dengue target based on loop recognition: at 40°C 
(top panel) and at 67°C (bottom panel). (B) Melting plots (0.01°C/s) of 
samples containing 1 pM target (red) and no template (blue) incubated with 
LV-MNPs after LAMP. Examples of the corresponding optomagnetic spectra 
are given in Fig. S3, ESI†. 
Subsequently, we performed real-time measurements during a 
temperature ramp to study the melting behaviour of the MNP-
amplicon conjugates. The corresponding 𝑽𝑽𝟐𝟐′  spectra reflected a 
decreasing hydrodynamic volume with increasing temperature due 
to melting of loop-LV probe hybrids. The melting temperatures for 
the true positive and spurious amplicons attached to the capture 
probe via loops differed by more than 20°C (Fig. 4B). The best 
discrimination was observed at temperatures in the range 65°C -
70°C. No change in the optomagnetic signal intensity was observed 
(compare Fig. 2A and Fig. S3A†).  
The obtained melting trends are consistent with the accumulation 
of base errors in spurious amplicons through its constant recycling 
in LAMP, which can also be observed by endonuclease restriction 
analysis.17 These mutations cause the large observed difference in 
melting temperatures (>20 °C) between spurious and true positive 
amplicons.  
Dose-response analysis of real-time data 
In these studies, all pipetting steps were performed in the same 
laboratory with no special precautions concerning cross-
contamination by amplicons from past LAMP reactions. Sequence-
specific validation of the LAMP products was employed by use of 
LV-MNPs for the readout in a real-time LAMP reaction at 67°C, 
where the melting studies showed negligible binding of LV-probes 
to spurious amplicons (Fig. 4).  
Optomagnetic spectra measured in real-time during LAMP on true 
positive samples (Fig. 5A) revealed a decrease of the negative peak 
at about 250 Hz from single LV-MNPs and the occurrence of a 
positive peak at low frequencies (1-20 Hz). Corresponding 
experiments on the NTC sample (Fig. 5B) showed only a small 
decrease of the intensity of the peak from single MNPs. Following 
our previous reports,32,33 the observations on the true positive 
sample are indicative of clustering of MNPs. Each MNP binds to a 
loop as illustrated in Fig. 5C. The observation of clustering of LV-
MNPs shows that several LV-MNPs are attached to each amplicon. 
Thus, the results show that each amplicon exposes several binding 
sites (loops) during the amplification. 
   
 
Fig. 5: Sequence-specific validation of loops in LAMP amplicons. (A)-(B) 
Optomagnetic spectra obtained at 67°C at different time points (red to blue) 
during LAMP reflecting multiple loops per amplicon and clustering in the 
case of (A) true-positive amplicons and (B) an NTC sample containing 
spurious amplicons. For more details, see Fig. S4, ESI†. (C)-(D) Schematic 
illustration of loops in specific and spurious amplicons targeted by LV probes 
attached to MNPs. 
As a result of the clustering, the optomagnetic spectra display 
depletion of single MNPs to different extent depending on the 
target concentration in the LAMP mixture. As the relevant (and 
simplest) signal for the dose-response analysis for a target 
concentration c, we therefore use the signal from free MNPs at 
time t (min) after initiation of the LAMP reaction, 𝑽𝑽�𝟐𝟐′ (𝒄𝒄, 𝒕𝒕), obtained 
as the average of the 𝑽𝑽𝟐𝟐′ -values in the range 100-500 Hz. To 
eliminate any influence of a small variation in the MNP 
concentration, we normalise the signal at time t with that obtained 
at time t = 0 where no LAMP products have formed such that we 
only study the relative depletion of free MNPs. Figure 6A shows the 
signal 𝑽𝑽�𝟐𝟐′ (𝒄𝒄, 𝒕𝒕)/𝑽𝑽�𝟐𝟐′ (𝒄𝒄,𝟎𝟎) vs. time during real-time LAMP for the 
indicated target concentrations. Figure 6B shows the end-point 
value, 𝑽𝑽�𝟐𝟐′ (𝒄𝒄,𝟐𝟐𝟎𝟎 𝐦𝐦𝐬𝐬𝐬𝐬)/𝑽𝑽�𝟐𝟐′ (𝒄𝒄,𝟎𝟎), vs. target concentration obtained 
from triplicate experiments. Using the 3σ criterion, we estimate an 
LOD of 100 fM of Dengue target DNA under the employed non-ideal 
conditions. 
  
Fig. 6: Optomagnetic detection of nanoclusters in LAMP. (A) Real-time 
monitoring of depletion of single MNPs for different target concentration in 
LAMP. The normalised average (100-500 Hz) signal 𝑽𝑽�𝟐𝟐′ (𝒄𝒄, 𝒕𝒕)/𝑽𝑽�𝟐𝟐′ (𝒄𝒄,𝟎𝟎) corresponding to single MNPs. (B) End-point value, 𝑽𝑽�𝟐𝟐′ (𝒄𝒄,𝟐𝟐𝟎𝟎 𝐦𝐦𝐬𝐬𝐬𝐬)/𝑽𝑽�𝟐𝟐′ (𝒄𝒄,𝟎𝟎), 
corresponding to the single, non-depleted MNPs. The dashed line is a fit of 
the logistic function 𝒚𝒚 = 𝟎𝟎.𝟔𝟔𝟔𝟔(𝟔𝟔) �𝟏𝟏 − �𝟏𝟏 + 𝟏𝟏𝟎𝟎(𝒄𝒄𝟎𝟎[𝐟𝐟𝐟𝐟]−𝒄𝒄[𝐟𝐟𝐟𝐟])𝒑𝒑�−𝟏𝟏� to the 
dose-response curve with 𝒄𝒄𝟎𝟎[𝐩𝐩𝐟𝐟] = 𝟐𝟐𝟏𝟏𝟐𝟐(𝟐𝟐𝟐𝟐) fM and 𝒑𝒑 = 𝟎𝟎.𝟎𝟎𝟎𝟎𝟔𝟔𝟎𝟎(𝟏𝟏𝟎𝟎). 
Numbers in parentheses indicate the uncertainty obtained from the fitting. 
The two blue lines show the NTC signal and the NTC signal minus 3σ used to 
calculate the LOD (n=3). The inset illustrates the elongation phase of LAMP 
for specific and spurious amplicons with and without MNP clustering, 
respectively. 
A minor depletion of MNPs took place also for the NTC sample 
(Figs. 5B and 6). We speculate that this loss of MNPs in the NTC 
sample is caused by sedimentation of MNPs because of attachment 
of the capture oligonucleotides to magnesium pyrophosphate. A 
similar phenomenon was observed using detection approach I (Fig. 
2A). At the end of an experiment, we observed an orange 
precipitate made from magnesium pyrophosphate and fraction of 
MNPs at the bottom of the chip. 
The above experiments were performed with LV-probes that were 
biotinylated at the 3’-end. When using MNPs functionalised with LF-
primers biotinylated at the 5’-end, the looped primer was inserted 
into the amplicon leading to a peak shift in 𝑽𝑽𝟐𝟐′  spectra in both NTC 
and D2 templated reactions (Fig. S5, Section S5, ESI†). However, 
MNP clusters were formed only in response to amplification of D2 
target as in the previously described case, but the clusters were 




Recently, we demonstrated automated optomagnetic detection 
of dengue fever that took just 8 minutes, required 6 μl of serum 
sample and showed a limit of detection of 25 ng/ml with an 
upper detection range of 20000 ng/mL.35 In that work, clustering 
took place because of affinity of non-structural protein (NS1) to 
MNP-bound monoclonal antibodies against NS1. The present 
work differs by implementing a molecular amplification strategy 
where clustering of DNA functionalised nanoparticles is mediated 
by LAMP amplicons in sequence-specific manner.  
The observation of clustering of LV-MNPs for true positive samples 
is found to be in good agreement with the mechanism of LAMP.2,3 
Elongation starts when an inner primer (for example, FIP) binds to 
the amplicon’s loop followed by unlocking of the loop and DNA 
displacement in the hairpin stem. Figure 1 illustrates the elongation 
phase in detail. A looped double-stranded structure (𝑳𝑳) undergoes 
unwinding of the stem during extension of the FIP (step 4). The FIP 
extension (step 5) results in the synthesis of a complementary 
strand of length 𝑳𝑳 (double stranded dsDNA) and an unlocked single 
stranded DNA (ssDNA) of the same length. The ssDNA part of this 
hybrid structure has multiple periodic self-annealing sites forming 
loops (often called cauliflower structures) with a loop at the 3’ end. 
The periodic loops can be used for binding looped primers (for 
example, LB) to accelerate the LAMP reaction.3 We used them as 
target for amplicon validation. The 3’-terminal loop is extended in 
step 6 leading to a fully double-stranded amplicon of double length 
and displacement of the previously synthesised “short copy”. 
Therefore, the length of amplicons in the elongation phase is 
doubled each time an inner primer binds to a loop on an amplicon 
(Fig. 1). 
Regarding detection approach I, we already mentioned about the 
better discrimination of amplicons using a biotinylated looped 
primer (Fig. 3). There, excess of MNP-free LF was preventing MNP 
clustering. In the asymmetric LF-free version of LAMP (detection 
approach II), exposure of long ssDNA tracts in the elongation phase 
allowed us to study sequence-specific clustering of MNPs. MNPs 
were observed to cluster very fast when the LV probes hybridised 
to the true positive amplicons via multiple binding sites in the 
exposed single-stranded DNA (Fig. 6A). The LV-MNPs were 
observed to remain bound (see cartoon in Fig. 6B). This 
demonstrates that time gap between steps 4 and 6 in Fig. 1 allows 
for sequence-specific hybridization of functionalised MNPs to the 
periodic loops.  
Amplification of spurious amplicons is a common problem in assays 
with exponential growth.17,26 Even though LAMP is triggered by the 
combination of four to six primers, there is a lack in the sequence 
specificity in the binding of the primers to its target. Additionally, 
the inner primers are usually very long (40-50 bases) and may form 
primer homodimers. Once appeared, spurious amplicons interfere 
with the dose-dependence of LAMP unless extra validation 
mechanisms are employed. Spurious amplicons increase the LOD 
and make nucleic acid amplification assays highly sensitive to the 
choice of threshold time. Aerosols containing LAMP amplicons can 
stay in the lab environment for many days. The 100 fM 
contamination level estimated for our laboratory environment 
agrees well with the work of Tan et al.26 who reported on 
exponential amplification of Herpes target with optical detection of 
gold nanoparticle clusters with detection of 1 pM target after 4 min. 
However, after additional 2 min, identical signals were observed 
from NTC and 1 pM Herpes samples.26 It is, therefore, very 
important to have a readout method that is not prone to detection 
of spurious amplicons. 
Different strategies to validate the output of LAMP have been 
demonstrated in the literature.9,16 However, no validation of 
amplicons in LAMP can decrease the LOD below the background 
level, i.e., the concentration of spurious amplicons that compete 
with the target template for dNTPs. For example, in the work of Li 
et al., the obtained LOD of a few copies was on the order of the 
background level (less than 1 aM).16 Further reducing the LOD can 
be pursued using betaine,21 MutS protein,22 single strand binding 
protein,23 or the UTP/UDG approach.25 
We propose the presented optomagnetic technique as a valuable 
tool to validate the specificity of LAMP amplicons and note that the 
disposable plastic chip has the potential to be mass-manufactured 
by injection moulding at very low cost. The sequence-specific 
validation of amplicons was introduced at a stage where our 
laboratory environment was contaminated with spurious amplicons 
with a concentration estimated to 100 fM (see Fig. S2, ESI†). The 
validation resulted in reproducible detection of true-positive targets 
at concentrations exceeding this background. Based on sequence 
alignment, we speculate that the designed probe will be capable of 
discriminating not only spurious amplicon, but also amplicons made 
from other serotypes (D1, D3, and D4). We also do see feasible 
performing multiplex amplification and detection of four Dengue 
serotypes by performing LAMP reactions in parallel in a multi-
chamber chip. Further optimisation of the assay, for example 
elimination of spurious amplicons,25 are topics of future work.  
Conclusions 
We investigated an optomagnetic technique for detection of 
Dengue Fever virus DNA. First, detection of less than 1 fM target 
was demonstrated under “ideal” laboratory conditions. This level is 
on the order of the required clinical sensitivity for early diagnostics 
of Dengue. In later stages, when the lab was contaminated with 
amplicons from previous reactions, we studied the specificity of 
amplicons via targeting of amplicon loops with a capture probe 
tethered to MNPs. We investigated the stability of this binding for 
true and false positive amplicons. A difference in Tm of more than 
20°C allowed us to discriminate between true and false positive 
signal at the LAMP operating temperature. The sequence-specific 
validation applied in real-time optomagnetic detection of LAMP led 
to binding of the capture probes to several loops on single 
amplicons, thereby linking MNPs together to form clusters in 
response to positive target amplification. Target concentrations 
above 100 fM were still clearly detectable in the optomagnetic 
signal after 20 min of LAMP reaction, whereas the NTC only 
underwent a change of optical turbidity. The sequence-specific 
validation approach allowed us to discriminate between true 
positive Dengue LAMP amplicons and spurious amplicons at the 
expense of a higher LOD. While we have not achieved the 
   
clinically relevant LOD for the detection of Dengue by this 
approach, we believe that the molecular validation approach 
used can serve as a reference that will benefit the wider 
isothermal amplification community. Our method benefits from 
real-time monitoring of the interaction between LAMP products 
and functionalised nanoparticles. This gives us insight into kinetics 
and mechanistic transformations of amplicons at the nanoscale, 
which helps in better understanding and tailoring of LAMP steps 
towards diagnostics. 
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